GNC Holdings Inc (GNC) 20.74 $GNC YY, GNC Holdings,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
GNC Holdings Inc (GNC) 20.74 $GNC

YY, GNC Holdings, Energous Corporation, Capital One, and eBay and more offer option-trading opportunities that offer returns of more than 20%
PR Newswire - Thu Sep 01, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for COF, EBAY, GNC, WATT, and YY.
YY: 52.92 (+1.16), WATT: 18.57 (+0.22), EBAY: 32.28 (+0.15), COF: 71.64 (+0.56), GNC: 20.74 (-0.07)

GNC Holdings Hit by Dismal Q2 Results, Competition Rife
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 8:12AM CDT
GNC Holdings (GNC) ended second-quarter 2016 on a disappointing note as its revenue figure failed to meet the Zacks Consensus Estimate.
GWPH: 82.73 (+0.45), GNC: 20.74 (-0.07), QDEL: 21.58 (-0.16), LNTH: 9.40 (-0.10)

Covered Call reports for Freeport-McMoRan, GNC Holdings, BP, TASER International and Boeing include trade ideas that offer returns of 20% or more!
PR Newswire - Wed Aug 17, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for BA, BP, FCX, GNC, and TASR.
GNC: 20.74 (-0.07), FCX: 10.48 (+0.13), BP: 34.50 (+0.84), TASR: 26.57 (-0.28), BA: 131.16 (+1.26)

GNC Holdings (GNC) Tops Q2 Earnings, Suspends '16 View
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 2:01PM CDT
GNC Holdings (GNC) ended second-quarter 2016 on a disappointing note as its revenue figure failed to meet the Zacks Consensus Estimate.
BABY: 40.64 (+0.93), ABMD: 117.43 (-0.20), MASI: 59.90 (+0.47), GNC: 20.74 (-0.07)


GNC CEO steps down, guidance suspended, shares plunge
AP - Thu Jul 28, 10:39AM CDT
PITTSBURGH (AP) — GNC, which has seen its stock halved over the past year, suspended its guidance for the year its chief executive is leaving the company after a failed turnaround attempt.
GNC: 20.74 (-0.07)

GNC Holdings (GNC) Tops Q2 Earnings and Revenues
Nabaparna Bhattacharya - Zacks Investment Research - Thu Jul 28, 7:43AM CDT
GNC Holdings reported second quarter earnings of 79 cents per share, which beat the Zacks Consensus Estimate by 3 cents.
GNC: 20.74 (-0.07)

GNC Holdings, Inc. Reports Second Quarter 2016 Results
PR Newswire - Thu Jul 28, 5:50AM CDT
GNC Holdings, Inc. (NYSE: GNC) (the "Company" reported consolidated revenue of $673.2 million, a decrease of 2.4% as compared with consolidated revenue of $689.6 million for the second quarter of 2015. As previously announced, beginning in the second quarter of 2016 the Company changed its reportable segments. Revenue in the U.S. & Canada segment decreased by 2.0%, revenue in the International segment decreased 2.5%, and revenue in the Manufacturing/Wholesale segment, excluding intersegment sales increased 5.3%.
GNC: 20.74 (-0.07)

GNC Names Robert F. Moran Interim CEO
PR Newswire - Thu Jul 28, 5:45AM CDT
GNC Holdings, Inc. (NYSE: GNC) (the "Company", a leading global specialty retailer of health, wellness and performance products, today announced that its board of directors ("GNC Board" has appointed Robert F. Moran, an Independent Director of GNC and former Chairman and Chief Executive Officer of PetSmart, Inc. ("PetSmart", as interim Chief Executive Officer, effective immediately. Mr. Moran replaces Michael G. Archbold, Chief Executive Officer, who is leaving the Company and has resigned from the GNC Board. Mr. Moran will remain on the GNC Board. The Company also announced that its previously announced strategic review process remains ongoing.
GNC: 20.74 (-0.07), PETM: 82.98 (+0.03)

The USATF Foundation Received Over $85,000 in Donations From GNC Customers, Associates and the GNC Live Well Foundation to Support Athletes' Dreams of Competing on the World's Biggest Stage This Summer in Rio
PR Newswire - Wed Jul 27, 1:29PM CDT
The USA Track & Field Foundation, in partnership with GNC, a leading global specialty retailer of health, wellness and performance products, raised over $85,000 during a month-long fundraising and awareness campaign at more than 4,300 GNC stores across the U.S. The USA Track & Field Foundation provides a means to attract and guide funds to new and innovative track & field programs, with an emphasis on providing opportunities for youth athletes, emerging elite athletes, and distance training centers. The USA Track & Field Foundation, launched in 2005, assists dedicated, aspiring world-class athletes of any age to realize their potential and dreams.
GNC: 20.74 (-0.07)

GNC Gains as Buyout Rumors of Vitamin Shoppe Resurface
Zacks Equity Research - Zacks Investment Research - Thu Jun 23, 5:32AM CDT
The Vitamin Shoppe buyout rumor first buzzed in immediately after GNC Holdings Inc.'s (GNC) earnings call in the last quarter.
BSX: 24.26 (-0.07), HLF: 61.35 (+0.18), BAX: 46.28 (+0.10), GNC: 20.74 (-0.07)

GNC to Present at the Jefferies 2016 Consumer Conference
PR Newswire - Fri Jun 10, 7:00AM CDT
GNC Holdings, Inc. (NYSE: GNC) (the "Company", a leading global specialty health, wellness and performance retailer, today announced that Mike Archbold, Chief Executive Officer, and Tricia Tolivar, Executive Vice President and Chief Financial Officer, will be presenting at the Jefferies 2016 Consumer Conference at the White Elephant in Nantucket, MA.
GNC: 20.74 (-0.07)

New Strong Sell Stocks for June 8th
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 8:31AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Wednesday
BIDU: 177.78 (+1.23), GNC: 20.74 (-0.07), TGLS: 12.60 (-0.01), BWLD: 161.61 (+0.64), HRB: 21.65 (+0.08)

GNC Holdings Q1 Results Weak, Overseas Prospects Bright
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 7:01AM CDT
GNC Holdings (GNC) made a disappointing start to its first quarter of 2016 with the results squarely missing the Zacks Consensus Estimate.
BSX: 24.26 (-0.07), SRDX: 29.48 (+1.24), BAX: 46.28 (+0.10), GNC: 20.74 (-0.07)

Hagens Berman Continues Investigation of Mislabeled "Dietary Supplements" Promoting Weight Loss, Muscle Gain and Fat Burning
BusinessWire - Tue May 10, 2:37PM CDT
Attorneys from Hagens Berman Sobol Shapiro, a leading consumer-rights law firm, alerts consumers to dietary supplements containing oxilofrine, a pharmaceutical stimulant not approved for use as a prescription drug or as a dietary supplement in the U.S.
GNC: 20.74 (-0.07)

Halliburton and Apollo Education trade higher, Baidu skids
AP - Mon May 02, 3:37PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq stock market:
DO: 16.28 (-0.23), BIDU: 177.78 (+1.23), GNC: 20.74 (-0.07), SYY: 53.24 (+1.18), HAL: 43.32 (+0.11), HP: 60.19 (-0.11), APOL: 8.90 (+0.01), BRCD: 9.02 (-0.04)

New Strong Sell Stocks for May 2nd
Zacks Equity Research - Zacks Investment Research - Mon May 02, 8:29AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Monday
CCLP: 9.67 (+0.15), ACW: 2.58 (+0.92), GNC: 20.74 (-0.07), EMG: 3.82 (+0.16), XLRN: 30.84 (+0.59)

GNC Commences Strategic And Financial Review To Increase Shareholder Value
PR Newswire - Mon May 02, 7:00AM CDT
GNC Holdings, Inc. (NYSE: GNC) (the "Company", a leading global specialty health, wellness and performance retailer, today announced that its Board of Directors has commenced a review of a wide range of strategic and financial alternatives to increase shareholder value. The review will include a thorough evaluation of the Company's current operating plan, as well as potential value maximizing alternatives such as accelerated refranchising strategies, capital structure optimization, partnerships and other value-creating collaborations, or a potential sale of the Company. The Board is working with Goldman, Sachs & Co. as financial advisor and Wachtell, Lipton, Rosen & Katz as legal advisor to assist in the process.
GNC: 20.74 (-0.07)

GNC Holdings (GNC) Q1 Earnings Lag, Cash Position Strong
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 12:39PM CDT
2016 started off on a disappointing note for GNC Holdings (GNC), with its first-quarter results squarely missing the Zacks Consensus Estimate.
BSX: 24.26 (-0.07), BAX: 46.28 (+0.10), GNC: 20.74 (-0.07), OFIX: 45.39 (-0.13)

Facebook and St. Jude Medical surge, GNC and AbbVie skid
AP - Thu Apr 28, 4:07PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq stock market:
MDVN: 80.85 (-0.08), ABT: 42.09 (-0.21), FB: 126.51 (+0.34), GNC: 20.74 (-0.07), HBI: 26.40 (-0.12), DWA: 40.97 (+0.01)

Why GNC Holdings Inc. Shares Tanked Today
Jeremy Bowman, The Motley Fool - Motley Fool - Thu Apr 28, 3:11PM CDT
What:  Shares of  GNC Holdings Inc.  were throwing in the towel today, tumbling after a terrible earnings report. As of 2:56 p.m. ET, the stock was down 28.5%. So what:  Weak earnings results and a guidance cut combined to sink the retailer. The...
GNC: 20.74 (-0.07)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 271

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 139

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 190

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Kearney's 2025 Global Cities Report Insights

Updated Category News Views 654

Global Cities Adapt to New Challenges and Emergence Global cities hold steady at the top as new hubs surge forward Top cities reaffirm their dominance in the Global Cities Index, showcasing remarkable resilience amidst global changes and uncertainties. The Global Cities Outlook indicates a noticeable shift as traditional leaders face turbulence, while emerging Gulf and...

Continue Reading
Vacca Family Law Group Enhances Support for Peaceful Divorce

Updated Category News Views 255

Empowering Families Through Non-Adversarial Divorce Solutions Families navigating the challenging process of separation now have renewed access to considerate and non-confrontational divorce options. Vacca Family Law Group has recently welcomed Attorney and Mediator Wendy Reimer, who brings nearly two decades of experience in family law and a strong background in...

Continue Reading
Ingredion Delivers Impressive Q3 Results, Upgrades Outlook

Updated Category News Views 55

Ingredion's Strong Performance in the Third Quarter Ingredion Incorporated (NYSE: INGR) has reported remarkable results for the third quarter of 2024, showcasing a noteworthy surge in both operating income and earnings per share (EPS). The global leader in ingredient solutions for the food and beverage industry achieved a stunning 26% increase in reported operating income...

Continue Reading
Insight into Learning Technologies Group Plc's Disclosure Mechanism

Updated Category News Views 193

Understanding the Public Opening Position Disclosure Process In the complex world of financial securities, understanding the disclosure requirements can feel daunting. However, the process outlined by the Takeover Code, particularly Rule 8.3, provides a structured approach for individuals and entities holding significant interests in relevant securities. This rule is...

Continue Reading
Avidity Biosciences Set to Inspire with Latest Presentations

Updated Category News Views 191

Avidity Biosciences' Key Presentations at the MDA Conference Avidity Biosciences, Inc. (Nasdaq: RNA), a pioneer in RNA therapeutics, is poised to make a significant impact at the upcoming Clinical and Scientific Conference organized by the Muscular Dystrophy Association (MDA). The event will showcase the latest advancements in the field and highlight groundbreaking...

Continue Reading